Pano, Bb Girl .
HRN: 25-57-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/06/2024
08/13/2024
IV
50 MG
Q 24 HRS
T/C NEONATAL SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes